Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Palmer

Showing results (391-400 of 466) with videos related to

Pageof 47
Sort By:
Journal of Diabetes and Its Complications|July 10, 2007
Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjectsRichard A Jensen, Lisa K Gilliam, Carina Törn, et al.
Diabetes|May 23, 2020
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention TrialsJay M Sosenko, Jay S Skyler, Kevan C Herold, et al.
Diabetes Care|September 10, 1999
Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosisG E Umpierrez, W Woo, W A Hagopian, et al.
Clinical Chemistry|April 19, 2008
Standardization of C-peptide measurementsRandie R Little, Curt L Rohlfing, Alethea L Tennill, et al.
Diabetes|May 1, 1990
Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family StudyD K McCulloch, L J Klaff, S E Kahn, et al.
Cancer|June 29, 2023
Assessing trends in breast care surveillance metrics after implementing surgeon-specific tracking and performance reporting in a large, integrated cancer networkRichard L White, Michelle L Wallander, Marjorie E Leighliter, et al.
Pediatric Diabetes|November 25, 2017
The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1Jay M Sosenko, Susan Geyer, Jay S Skyler, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Prognostic factors for the course of beta cell function in autoimmune diabetesC Törn, M Landin-Olsson, A Lernmark, et al.
Psychological Medicine|May 27, 2024
Latent profile analysis reveals overlapping ARFID and shape/weight motivations for restriction in eating disordersSophie R Abber, Kendra R Becker, Casey M Stern, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1996
Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) GroupI Kockum, A Lernmark, G Dahlquist, et al.
Pageof 47

Showing results (391-400 of 466) with videos related to

Sort By:
Pageof 47
Journal of Diabetes and Its Complications|July 10, 2007
Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjectsRichard A Jensen, Lisa K Gilliam, Carina Törn, et al.
Diabetes|May 23, 2020
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention TrialsJay M Sosenko, Jay S Skyler, Kevan C Herold, et al.
Diabetes Care|September 10, 1999
Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosisG E Umpierrez, W Woo, W A Hagopian, et al.
Clinical Chemistry|April 19, 2008
Standardization of C-peptide measurementsRandie R Little, Curt L Rohlfing, Alethea L Tennill, et al.
Diabetes|May 1, 1990
Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family StudyD K McCulloch, L J Klaff, S E Kahn, et al.
Cancer|June 29, 2023
Assessing trends in breast care surveillance metrics after implementing surgeon-specific tracking and performance reporting in a large, integrated cancer networkRichard L White, Michelle L Wallander, Marjorie E Leighliter, et al.
Pediatric Diabetes|November 25, 2017
The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1Jay M Sosenko, Susan Geyer, Jay S Skyler, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Prognostic factors for the course of beta cell function in autoimmune diabetesC Törn, M Landin-Olsson, A Lernmark, et al.
Psychological Medicine|May 27, 2024
Latent profile analysis reveals overlapping ARFID and shape/weight motivations for restriction in eating disordersSophie R Abber, Kendra R Becker, Casey M Stern, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 1, 1996
Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) GroupI Kockum, A Lernmark, G Dahlquist, et al.
Pageof 47